Loading organizations...
§ Private Profile · Vancouver, WA, USA
Generative AI drug creation company using synthetic biology to discover and design novel biologic drugs for biopharmaceutical partners.
Absci has raised $32.5M across 3 funding rounds.
Key people at Absci.
Absci has raised $32.5M in total across 3 funding rounds.
Based in Vancouver, Washington, Absci is a generative AI drug creation company that combines artificial intelligence with synthetic biology to discover, design, and optimize novel protein-based therapeutics. The publicly traded biotechnology firm operates with approximately 200 employees and reached a market capitalization of nearly $2 billion during its 2021 initial public offering on the NASDAQ. Having raised over $530 million in total capital, the organization utilizes custom-engineered E. coli strains to integrate computational models with wet-lab data for high-throughput screening of biologic drug candidates. The company generates revenue through strategic research partnerships and milestone agreements with major industry players, including Merck, AstraZeneca, NVIDIA, and Almirall. Notably, the firm recently secured a collaboration with AstraZeneca worth up to $247 million to engineer a new oncology antibody. Absci was originally founded in 2011 by entrepreneur Sean McClain.
Absci has raised $32.5M across 3 funding rounds. Most recently, it raised $15.4M Debt / Series D in January 2020.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jan 14, 2020 | $15.4M Debt Financing | JSR Life Sciences, KBI Biopharma | Columbia Ventures Corporation, Oregon Venture Fund, Phoenix Venture Partners, WRF Capital | Announced |
| May 30, 2018 | $12M Series C | Gustavo Mahler | Columbia Ventures Corporation, Greenbridge, Oregon Venture Fund, Zach Jonasson, VentureSouth, WRF Capital | Announced |
| Apr 25, 2016 | $5.1M Series A | Zach Jonasson | — | Announced |
Absci has raised $32.5M in total across 3 funding rounds.
Absci's investors include JSR Life Sciences, KBI Biopharma, Columbia Ventures Corporation, Oregon Venture Fund, Phoenix Venture Partners, WRF Capital, Gustavo Mahler, GreenBridge, Zach Jonasson, VentureSouth.
Key people at Absci.
